Seer Board Defends Against Activist Bid, Cites Scientific Progress and $24.5M Share Buybacks
Summary
Seer's Board issued a letter to shareholders defending its strategy and urging votes for its nominees ahead of the July 28 Annual Meeting. This follows an ongoing proxy contest and multiple unsolicited acquisition proposals from activist investors Radoff and Torok. The Board highlighted significant scientific progress, commercial momentum with a 67% installed base expansion, and disciplined financial management, including a 19.3% reduction in 2025 operating expenses and the repurchase of $24.5 million in shares since 2024. The letter aims to convince shareholders to support the current board over the activist's 'short-sighted campaign' and proposals, which the board claims are below the company's cash value. The outcome of the Annual Meeting on July 28, 2026, will determine the company's future direction.
At the time of this announcement, SEER was trading at $1.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $95.1M. The 52-week trading range was $1.65 to $2.41. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.